New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2014
08:10 EDTLJPCLa Jolla Pharmaceutical, GW University enter into agreement related to LJPC-501
La Jolla Pharmaceutical announced that it has signed an option agreement with the George Washington University that will add proprietary technology to the company’s LJPC-501 program. The option agreement with GW adds potential proprietary protection to La Jolla’s pipeline, which includes treatments for chronic kidney disease, hepatorenal syndrome, chronic iron overload, and rare diseases.
News For LJPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
08:03 EDTLJPCLa Jolla initiates phase 3 trial of LJPC-501
Subscribe for More Information
March 18, 2015
08:06 EDTLJPCLa Jolla announces initiation of Phase 2b trial of GCS-100
Subscribe for More Information
March 16, 2015
16:40 EDTLJPCLa Jolla reports Q4 EPS (45c), consensus (37c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use